Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).
A patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker behind the treatment said on Friday, in a world first following its conditional approval in the country.
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.
FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer’s disease
A single dose of an antibody targeting immune cells helped some monkeys stay free of detectable virus long after stopping treatment.
StimCardio, a Los Angeles, CA-based clinical-stage medical device company developing non-invasive wearable therapeutics for atrial fibrillation (AF), has announced the closing of its oversubscribed $30 million Series A financing.
Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC), according to a new study published in the Journal of Clinical Investigation.
For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell. Now, new work led by researchers at the University of Michigan Health Rogel Cancer Center found that tumor cells could be killed even when major granzymes were missing.
MIT engineers designed a robotic enteroscope that can inch through the hard-to-reach small intestine, making biopsies and drug delivery easier.
BOSTON, Oct. 28, 2026 /PRNewswire/ — Empatica, a leader in digital biomarker development and clinical-grade wearable technology, today announced WellPD, an FDA-cleared and CE-marked wearable device and companion app for people with Parkinson’s to monitor their symptoms at home.